How has been the historical performance of Chandan Healthca?

Answer:Chandan Healthca has shown significant growth in its financial performance over the past three years, particularly from March 2023 to March 2025.

Breakdown:
In terms of net sales, Chandan Healthca increased its revenue from 136.89 Cr in March 2023 to 230.12 Cr in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 136.89 Cr to 230.12 Cr during the same period. The company's total expenditure also grew, from 127.51 Cr in March 2023 to 188.79 Cr in March 2025, with notable increases in raw material costs and employee costs. Operating profit, excluding other income, surged from 9.38 Cr in March 2023 to 41.33 Cr in March 2025, indicating improved operational efficiency. Profit before tax rose significantly from 5.01 Cr to 32.06 Cr, and profit after tax increased from 3.59 Cr to 23.52 Cr, showcasing robust profitability growth. The earnings per share (EPS) also improved markedly from 1.69 to 9.07 over the same period. On the balance sheet, total assets grew from 76.12 Cr in March 2022 to 210.62 Cr in March 2025, while total liabilities increased from 42.05 Cr to 56.88 Cr, indicating a solid asset base. Cash flow from operating activities showed a negative trend, moving from a positive 6.00 Cr in March 2022 to a negative 29.00 Cr in March 2025, although net cash inflow remained positive at 2.00 Cr by March 2025. Overall, Chandan Healthca's performance reflects a strong growth trajectory in sales and profitability, despite challenges in cash flow management.